Latest & greatest articles for folic acid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on folic acid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on folic acid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for folic acid

1. Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication

Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication Final Recommendation Statement: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 11/16/2018 6:27:19 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication (...) Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Women who are planning or capable of pregnancy The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid. To read

2017 U.S. Preventive Services Task Force

2. Folic acid

Folic acid Top results for folic acid - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for folic acid The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

3. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies Full Text available with Trip Pro

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 37, Issue 6, Pages 534 (...) –549 Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies PRINCIPAL AUTHOR, x R. Douglas Wilson , MD Calgary AB x GENETICS COMMITTEE x R. Douglas Wilson , MD (Chair) x R. Douglas Wilson , x François Audibert , MD x François Audibert , x Jo-Ann Brock , MD x Jo-Ann Brock , x June Carroll , MD x June Carroll , x Lola Cartier , MSc x Lola Cartier , x Alain Gagnon , MD x Alain Gagnon

2015 Society of Obstetricians and Gynaecologists of Canada

4. Intermittent iron and folic acid supplementation in non-anaemic pregnant women

Intermittent iron and folic acid supplementation in non-anaemic pregnant women WHO | Archived: Intermittent iron and folic acid supplementation in non-anaemic pregnant women Archived This publication and its contents has been superseded by a more recent version. It is here for reference purposes. Please follow WHO Regional websites Access Nutrition Menu Archived: Intermittent iron and folic acid supplementation in non-anaemic pregnant women Guideline Authors : World Health Organization (...) Publication details Number of pages : 26 Publication date : 2012 Languages : English, Farsi, Portuguese, Spanish ISBN : 978 92 4 150201 6 Downloads pdf, 1.20Mb pdf, 661.67kb pdf, 807kb Overview This guideline provides global, evidence-informed recommendations on intermittent iron and folic acid supplementation as a public health intervention for the purpose of improving pregnancy outcomes and reducing maternal anaemia in pregnancy. The guideline will help Member States and their partners in their efforts

2012 World Health Organisation Guidelines

5. Folic acid and risk of twinning: a systematic review of the recent literature, July 1994 to July 2006

Folic acid and risk of twinning: a systematic review of the recent literature, July 1994 to July 2006 Folic acid and risk of twinning: a systematic review of the recent literature, July 1994 to July 2006 Folic acid and risk of twinning: a systematic review of the recent literature, July 1994 to July 2006 Muggli E E, Halliday J L CRD summary The authors concluded that there is evidence of a possible association between periconceptional folic acid and the risk of twinning, but further research (...) is required. The authors' cautious conclusions appear to reflect the limited data, but the poorly defined review question, inadequate reporting of the review methods and inadequate quality assessment make it difficult to assess the reliability of these conclusions. Authors' objectives To examine the association between periconceptional folic acid (FA) supplementation and fortification of foods with FA and the risk of twinning. Searching The Cochrane Library (Issue 4, 2005), MEDLINE via PubMed, MEDLINE

2007 DARE.

6. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Wolff T, Witkop CT, Miller T, Syed SB Record Status This is a bibliographic (...) record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Wolff T, Witkop CT, Miller T, Syed SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 70. 2009 Authors' objectives To update the evidence on folic acid

2009 Health Technology Assessment (HTA) Database.

7. The long-term impact of folic acid in pregnancy on offspring DNA methylation: follow-up of the Aberdeen Folic Acid Supplementation Trial (AFAST) Full Text available with Trip Pro

The long-term impact of folic acid in pregnancy on offspring DNA methylation: follow-up of the Aberdeen Folic Acid Supplementation Trial (AFAST) It has been proposed that maternal folic-acid supplement use may alter the DNA-methylation patterns of the offspring during the in-utero period, which could influence development and later-life health outcomes. Evidence from human studies suggests a role for prenatal folate levels in influencing DNA methylation in early life, but this has not been (...) extended to consider persistent effects into adulthood.To better elucidate the long-term impact of maternal folic acid in pregnancy on DNA methylation in offspring, we carried out an epigenome-wide association study (EWAS) nested within the Aberdeen Folic Acid Supplementation Trial (AFAST-a trial of two different doses: 0.2 and 5 mg, folic acid vs placebo). Offspring of the AFAST participants were recruited at a mean age of 47 years and saliva samples were profiled on the Illumina Infinium Human

2018 International journal of epidemiology Controlled trial quality: uncertain

8. Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health

Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02221752 Recruitment Status : Completed First Posted : August 20, 2014 Last Update Posted : August 20, 2014

2014 Clinical Trials

9. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy

A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

10. Folic acid to reduce neonatal mortality from neural tube disorders

Folic acid to reduce neonatal mortality from neural tube disorders Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

11. Association of neural tube defects and folic acid food fortification in Canada. (Abstract)

Association of neural tube defects and folic acid food fortification in Canada. Many women do not receive folic acid supplements before conception. In response, most of Canada's cereal grain products were being fortified with folic acid by January, 1998, thereby providing an additional 0.1-0.2 mg per day of dietary folate to the Canadian population. We assessed the effect of supplementation on prevalence of open neural tube defects in the province of Ontario. Among 336 963 women who underwent (...) maternal serum screening over 77 months, the prevalence of open neural tube defects declined from 1.13 per 1000 pregnancies before fortification to 0.58 per 1000 pregnancies thereafter (prevalence ratio 0.52, 95% CI 0.40-0.67, p<0.0001). At a population level, folic acid food fortification is associated with a pronounced reduction in open neural tube defects.

2002 Lancet

12. Folic acid

Folic acid Folate - Wikipedia Folate From Wikipedia, the free encyclopedia (Redirected from ) Folic acid Clinical data Pronunciation Synonyms FA, N -(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)- L -glutamic acid, pteroyl-L-glutamic acid, vitamin B 9 , vitamin B c , vitamin M, folacin, pteroyl-L-glutamate / (No risk in human studies) By mouth, IM, IV, sub-Q ( ) Legal status data 50–100% Liver Urine Identifiers (2 S )-2-[[4-[(2-Amino-4-oxo-1 H -pteridin-6-yl)methylamino (...) , distinct forms of which are known as folic acid , folacin , and vitamin B 9 , is one of the . It may be taken by mouth or by injection. The recommended adult daily intake of folate in the U.S. is 400 from foods or . Folate in the form of folic acid is used to treat caused by . Folic acid is also used as a by women during to reduce the risk of (NTDs) in the baby. Low levels in early are believed to be the cause of more than half of babies born with NTDs. More than 80 countries use with folic acid

2012 Wikipedia

13. Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring. Full Text available with Trip Pro

Association of Maternal Use of Folic Acid and Multivitamin Supplements in the Periods Before and During Pregnancy With the Risk of Autism Spectrum Disorder in Offspring. The association of maternal use of folic acid and multivitamin supplements before and during pregnancy with the risk of autism spectrum disorder (ASD) in offspring is unclear.To examine the associations between the use of maternal folic acid and multivitamin supplements before and during pregnancy and the risk of ASD (...) in offspring.A case-control cohort study of 45 300 Israeli children born between January 1, 2003, and December 31, 2007, were followed up from birth to January 26, 2015, for the risk of ASD. The cases were all children diagnosed with ASD and the controls were a random sample of 33% of all live-born children.Maternal vitamin supplements were classified for folic acid (vitamin B9), multivitamin supplements (Anatomical Therapeutic Chemical A11 codes vitamins A, B, C, and D), and any combination thereof exposed

2018 JAMA psychiatry (Chicago, Ill.)

14. Demand and supply factors of iron-folic acid supplementation and its association with anaemia in North Indian pregnant women. Full Text available with Trip Pro

Demand and supply factors of iron-folic acid supplementation and its association with anaemia in North Indian pregnant women. Anaemia prevalence in pregnant women of India declined from 57.9% to 50.3% from National Family Health Survey (NFHS)-3 to NFHS-4. However, over the course of that decade, the uptake of iron and folic acid (IFA) supplementation for 100 days of pregnancy improved by only 15%. To understand demand side risk factors of anaemia specifically related to IFA intake, an in-depth

2019 PLoS ONE

15. Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding

Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding DOI 10.1212/WNL.0b013e3181a6b325 2009;73;142-149 Published Online before print April 27, 2009 Neurology C. L. Harden, P. B. Pennell, B. S. Koppel, et al. of Neurology and American Epilepsy Society Technology Assessment Subcommittee of the American Academy the Quality Standards Subcommittee and Therapeutics and Vitamin K, folic acid, blood levels (...) , MD J. Hopp, MD T.Y. Ting, MD W.A. Hauser, MD D.Thurman,MD,MPH P.W.Kaplan,MB,FRCP J.N. Robinson, MD J.A. French, MD S. Wiebe, MD A.N. Wilner, MD B. Vazquez, MD L. Holmes, MD A. Krumholz, MD R. Finnell, PhD P.O. Shafer, RN, MN C. Le Guen ABSTRACT Objective:To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid use, prenatal vitamin K use, risk of hemorrhagic disease of the newborn, clinical implications

2009 American Epilepsy Society

16. Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse Full Text available with Trip Pro

Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics (...) and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ

2009 DARE.

17. Daily iron and folic acid supplementation in pregnant women

Daily iron and folic acid supplementation in pregnant women WHO | Archived: Daily iron and folic acid supplementation in pregnant women Archived This publication and its contents has been superseded by a more recent version. It is here for reference purposes. Please follow WHO Regional websites Access Nutrition Menu Archived: Daily iron and folic acid supplementation in pregnant women Guideline Authors : World Health Organization Publication details Number of pages : 27 Publication date : 2012 (...) Languages : English, Portuguese, Spanish ISBN : 978 92 4 150199 6 Downloads pdf, 1.045Mb pdf, 862.5kb Overview This guideline provides global, evidence-informed recommendations on daily iron and folic acid supplementation in pregnant women as a public health intervention for the purpose of improving pregnancy outcomes and reducing maternal anaemia in pregnancy. The guideline will help Members States and their partners in their efforts to make informed decisions on the appropriate nutrition actions

2012 World Health Organisation Guidelines

18. Folate/folic Acid

Folate/folic Acid Folate — Health Professional Fact Sheet Font Size Decrease Font Size Increase Font Size Strengthening Knowledge and Understanding of Dietary Supplements Consumer information in Spanish Share: Search the ODS website Submit Search NIH Office of Dietary Supplements Folate Fact Sheet for Health Professionals Have a question? Ask ODS: Table of Contents Introduction Folate is a water-soluble B vitamin that is naturally present in some foods, added to others, and available (...) as a dietary supplement. "Folate," formerly known as "folacin" and sometimes "vitamin B9," is the generic term for naturally occurring food folates, and folates in dietary supplements and fortified foods, including folic acid. Food folates are in the tetrahydrofolate (THF) form and usually have additional glutamate residues, making them polyglutamates [ ]. Folic acid is the fully oxidized monoglutamate form of the vitamin that is used in fortified foods and most dietary supplements. Some dietary

2009 National Centre for Complementary and Alternative Medicine

19. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T (...) , Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V CRD summary The authors concluded that folic acid based homocysteine lowering therapy did not reduce cardiovascular events in people with kidney disease, and should not be used as a preventive treatment. Overall, this was a well-conducted review and the conclusion is likely to be reliable. Authors' objectives To evaluate the effect of folic acid based homocysteine lowering on cardiovascular outcomes in people with kidney disease. Searching

2012 DARE.

20. Folic Acid Supplementation in Pregnant Women: Dose Response

Folic Acid Supplementation in Pregnant Women: Dose Response Folic Acid Supplementation in Pregnant Women: Dose Response - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Folic Acid Supplementation in Pregnant (...) provided by (Responsible Party): Lynn B. Bailey, PhD, University of Georgia Study Details Study Description Go to Brief Summary: The proposed study is a double-blind randomized controlled trial in healthy pregnant women (BMI 18.5 - 29.9 kg/m2, age 18 - 40 yr) receiving prenatal care at Athens Regional Midwifery clinic (ARMC). The primary goal of the proposed study is to determine relative changes in blood folate and DNA methylation levels in response to 2 different supplemental doses of folic acid one

2014 Clinical Trials